Medical Device Industry Latest News Report (Updated April 22, 2026)

<h2>Domestic News</h2><h3>Abbott Japan Launches "GLP systems Track" Specimen Testing Automation System in Japan</h3><p><strong>【Company/Organization】</strong> Abbott Japan LLC<br><strong>【Category】</strong> New Products/Technological Innovations</p><p>On April 21, 2026, Abbott Japan LLC renewed the showroom of its Diagnostics Division within its Mita Office in Tokyo and commenced domestic sales of the "GLP systems Track" specimen testing automation system. This system automates the specimen transportation process from blood collection to results reporting and has been introduced in approximately 600 facilities worldwide as of March 2026. As part of Abbott's initiative to optimize the "Diagnosis Cycle," it supports the efficiency of in-hospital logistics through multidisciplinary collaboration.</p><p>The automation of specimen transportation directly leads to a reduction in the workload of laboratory staff and an improvement in testing accuracy. It is expected that the accelerated adoption, primarily in large hospitals, will standardize and streamline clinical testing in Japan. Furthermore, it serves as an example that re-emphasizes the importance of operational reform through robotics and automation in medical settings facing severe labor shortages.</p><h3>Medtec Japan 2026 Opens at Tokyo Big Sight (April 21-23)</h3><p><strong>【Company/Organization】</strong> Informa Markets Japan Co., Ltd. (Organizer)<br><strong>【Category】</strong> Events/Industry Trends</p><p>Medtec Japan 2026, the largest specialized exhibition in Japan dedicated to medical device design, manufacturing, components, and materials, is being held at Tokyo Big Sight from Monday, April 21 to Wednesday, April 23, 2026. Numerous medical device manufacturers and suppliers from Japan and overseas are exhibiting, showcasing the latest manufacturing technologies, materials, and regulatory compliance solutions.</p><p>This exhibition provides a valuable opportunity for suppliers involved in medical device manufacturing and development to conduct direct business negotiations with finished product manufacturers. It is attracting significant attention from industry stakeholders, particularly as an opportunity to accelerate product development for pharmaceutical affairs applications (PMDA approval) and to grasp the latest trends in components and manufacturing processes that comply with domestic and international regulatory requirements.</p> <h2>International News</h2><h3>AcuityMD Raises $80 Million for AI Commercial Intelligence in Medical Devices</h3><p><strong>【Company/Organization】</strong> AcuityMD (USA)<br><strong>【Category】</strong> Funding & Innovation</p><p>AcuityMD, a U.S. company, has completed an $80 million Series C funding round (approximately 12 billion JPY) to expand its AI-powered commercial intelligence platform for medical device manufacturers. The company's platform assists in developing sales strategies for medical devices, identifying market opportunities, and optimizing sales teams. Major medtech companies such as Medtronic, Stryker, and Boston Scientific are listed as its clients.</p><p>The importance of data-driven sales and marketing strategies utilizing AI is increasing in the medical device industry. This funding could accelerate the market penetration of medical devices and change how new technologies are delivered to patients. Particularly in new product market entry strategies, highly accurate AI-driven targeting is becoming a source of competitive advantage.</p><h3>Boston Scientific Shareholders File Lawsuit Over Electrophysiology Disclosure</h3><p><strong>【Company/Organization】</strong> Boston Scientific (USA)<br><strong>【Category】</strong> Legal & Compliance</p><p>It has been reported that Boston Scientific shareholders have filed a class-action lawsuit concerning the accuracy of disclosures regarding products in the electrophysiology (EP) field. The complaint alleges that the company provided misleading information to investors regarding the competitive advantage of its Pulse Field Ablation (PFA) technology.</p><p>The accuracy of information disclosure regarding product efficacy and safety is once again being questioned for medical device manufacturers. As demands for transparency from both investors and healthcare institutions increase, strengthening compliance systems is a challenge for the entire industry. Particularly in the rapidly growing PFA market, legal and regulatory scrutiny of companies' competitive claims may intensify.</p> <h2>Summary</h2><p>As of April 22, 2026, new products for automating and streamlining specimen testing are being introduced domestically, while large investments in AI-powered medical device commercial intelligence continue overseas. Furthermore, demands for compliance and transparency in information disclosure from medical device manufacturers are increasing, making the strengthening of regulatory and legal responses a critical issue for the entire industry. With the opening of Medtec Japan 2026, revitalization of the domestic manufacturing and development ecosystem is also anticipated.</p><h2>References</h2><ul> <li><a href="https://www.logi-today.com/" target="_blank" rel="noopener">LOGISTICS TODAY: Abbott Japan renovates showroom for automated specimen transport system</a></li> <li><a href="https://www.medtecjapan.com/" target="_blank" rel="noopener">Medtec Japan 2026 Official Website</a></li> <li><a href="https://lasvegassun.com/news/2026/apr/21/acuitymd-lands-80-million-in-new-funding-to-fuel-a/" target="_blank" rel="noopener">Las Vegas Sun: AcuityMD lands $80 million in new funding</a></li> <li><a href="https://www.mddionline.com/medical-device-markets/shareholders-suing-boston-scientific-over-electrophysiology-claims" target="_blank" rel="noopener">MDDI Online: Shareholders suing Boston Scientific over electrophysiology claims</a></li></ul>